Status: current, Defined. Date: 31-Mar 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2277091000168118 | bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2277101000168111 | bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | Is a | bemotrizinol + octocrylene + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | true | Inferred relationship | Some | ||
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has manufactured dose form | lotion | true | Inferred relationship | Some | ||
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has unit of use | continuous | true | Inferred relationship | Some | 1771007621 | |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has Australian BoSS | titanium dioxide | true | Inferred relationship | Some | 374360758 | |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has intended active ingredient | titanium dioxide | true | Inferred relationship | Some | 374360758 | |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has intended active ingredient | bemotrizinol | true | Inferred relationship | Some | 991994198 | |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has Australian BoSS | bemotrizinol | true | Inferred relationship | Some | 991994198 | |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has Australian BoSS | diethylamino hydroxybenzoyl hexyl benzoate | true | Inferred relationship | Some | 1244792822 | |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has intended active ingredient | diethylamino hydroxybenzoyl hexyl benzoate | true | Inferred relationship | Some | 1244792822 | |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has intended active ingredient | octocrylene | true | Inferred relationship | Some | 1771007620 | |
| bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | has Australian BoSS | octocrylene | true | Inferred relationship | Some | 1771007620 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 500 mL | has MPUU | True | bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | Inferred relationship | Some | 1 |
| bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 200 g | has MPUU | True | bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | Inferred relationship | Some | 1 |
| bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 125 mL | has MPUU | True | bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | Inferred relationship | Some | 1 |
| Sunsense Ultra SPF 50+ lotion (Old Formulation 2018) | Is a | True | bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | Inferred relationship | Some | |
| bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 60 mL | has MPUU | False | bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | Inferred relationship | Some | 1 |
| bemotrizinol 1% + octocrylene 2% + diethylamino hydroxybenzoyl hexyl benzoate 3.5% + titanium dioxide 2% lotion, 50 mL | has MPUU | True | bemotrizinol 10 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 35 mg / 1 g + octocrylene 20 mg / 1 g + titanium dioxide 20 mg / 1 g lotion (medicinal product unit of use) | Inferred relationship | Some | 928195780 |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product unit of use reference set
FHIR